Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
ALKS
Alkermes plc.
NASDAQ · Pharmaceutical Preparations
Last close
$40.61
· 2026-10-09
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Pharmaceutical Preparations
Market cap
$6.80B
RECENT INSIDER TRADES
2026-10-09
· Reed Joshua
(SVP, Chief Financial Officer)
· OTHER
2026-10-02
· Gaffin David Joseph
(EVP, CLO, Alkermes, Inc.)
· SELL
2026-09-03
· Gaffin David Joseph
(EVP, CLO, Alkermes, Inc.)
· SELL
2026-09-01
· Hopkinson Craig C.
(EVP R&D, Chief Medical Officer)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
453
Shares held
229,077,977
Value
$10.14B
Percent of shares outstanding
136.55%
As of quarter end
2026-06-30
RECENT CONGRESSIONAL TRADES
2026-07-30
· Hon. Gilbert Cisneros · BUY
· $15,001 - $50,000
2026-07-29
· Gilbert Cisneros · BUY
· $15,001 - $50,000
RECENT NEWS
Alkermes: Idiopathic Hypersomnia Could Expand Lumryz Into A Larger Growth And Margin Driver
Goldman Sachs resumes Alkermes stock coverage with neutral rating
Alkermes faces competition from Takeda and Lilly in orexin market
Alkermes rises on phase 1 results for ADHD drug ALKS 7290
Alkermes stock jumps on positive ADHD drug trial results
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Alkermes plc. (ALKS) · Stock Price, Insider Trades, Congress Trades · CatalystPit